Characteristics of biomarker on dermal sensitization for myocardial ischemia-reperfusion injury
- Conditions
- myocardial ischemia reperfusion injury
- Registration Number
- ITMCTR2024000180
- Lead Sponsor
- the Affiliated Hospital of Shaanxi University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
MIRI patients:
(1) meeting the diagnostic criteria of non-ST elevation acute coronary syndrome in 2023 ESC Guidelines for the management of acute coronary syndromes.
(2) received percutaneous coronary intervention within a week.
(3) aged 18 to 85 years.
(4) willing to participate in this study, and sign on informed consent.
Healthy subjects:
(1) received a health examination within a week, and confirmed to be in good health.
(2) aged 18 to 85 years, and matching the MIRI patients.
(3) willing to participate in this study, and sign on informed consent.
(1) diagnosed as ST-elevation myocardial infarction, with persistent ST-segment elevation or ST-segment elevation equivalents on electrocardiogram.
(2) combined with disorders of rhythm, disorders of the heart, muscles, valves, and pericardium, and peripheral vascular disease.
(3) suffering from neoplastic disorders, hematopoietic disorders, disorders of hemostasis, infectious diseases, immune-mediated, inflammatory, and rheumatologic disorders.
(4) combined with fever.
(5) suffering from psychiatric disorders, and unable to cooperate.
(6) participating in any other study using an unapproved drug within 3 months.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mRNA;
- Secondary Outcome Measures
Name Time Method